This Is HCM Real Talk

Patients with HCM are talking to their cardiologists
about advances
in treatment options

Hypertrophic cardiomyopathy (HCM)

is a serious heart condition affecting anywhere from 1 in 500 people,* to as many as

*The 1995 CARDIA study, a multicenter, US-population-based echocardiography study of 4111 subjects (aged 23-35), identified the prevalence of HCM as 1:500 people in the general population.

The 2015 Semsarian publication identified that the prevalence of HCM gene carriers could be as high as 1:200.

Common symptoms of HCM include shortness of breath, tiredness, rapid heartbeat,
chest pain, feeling dizzy or light-headed, fainting, and fatigue.

Treatment Options

Medication that
treats symptoms

Beta blockers, calcium channel blockers,
and/or disopyramide.

Commonly used to help treat the
symptoms of HCM but most are not FDA
approved for this use.

Surgery that
treats obstruction

Septal reduction therapy includes alcohol
septal ablation
and septal myectomy.

Used for severe obstruction or when
HCM continues to worsen even
with medication.

Medication that treats symptoms and obstruction

A treatment option that works inside the heart
muscle to treat HCM.

FDA approved to treat symptomatic obstructive HCM.

To learn more about a treatment option, click here.

Talking to Your Cardiologist

quotes quotes

Nicole was still short of breath on a
blocker so she did her research
and asked
her cardiologist about
advances in HCM.

quotes quotes

If you have been diagnosed with obstructive HCM and still have
symptoms on your current treatment, talk to your cardiologist.
Find out what treatment advances may be out there for you.